**INTRODUCTION:** Randomized controlled trials (RCTs) are considered the gold standard in evidence-based medicine. We conducted a systematic review to evaluate the quantity, quality, and trends of RCTs that assess surgical treatment of carpal tunnel syndrome (CTS).

**METHODS:** We identified RCTs comparing two or more surgical interventions for CTS in PubMed, Cochrane, Scopus, Google Scholar, and Clinicaltrials.gov. Two independent reviewers assessed manuscripts for inclusion. RCT characteristics including year, journal, country, funding, study size, methodology, follow-up, and intention-to-treat analysis were collected. For all studies, we calculated the Jadad scale^1^ (0--5), a validated instrument for assessing the methodological quality of RCTs. The Kendall rank correlation was used to assess trends of RCTs over time.

**RESULTS:** Of 2253 identified studies, 58 met full inclusion criteria. They were published between 1985--2015, with a significant increase in the number published over time (*p*=0.003). The majority were published in *Journal of Hand Surgery -- European Volume* (n=15, 25.9%), *Journal of Bone and Joint Surgery* (n=9, 15.5%), and *Journal of Hand Surgery -- American Volume* (n=8, 13.8%). Most RCTs were single-center studies (n=54, 93.1%) conducted in the UK (n=13, 22.4%) or the US (n=10, 17.2%), with a mean study size of 80.1 ± 55.5 patients. Funding source was unknown in 62.1% (n=36). Three-quarters (n=44, 75.9%) of RCTs did not define primary outcome measure(s); of those that did, less than half (n=6, 42.9%) specified them before beginning the RTC. \<30% (n=17) of RCTs conducted a power analysis. In regards to follow-up, 31.0% (n=18) had complete follow-up, 36.2% (n=21) lost some patients to follow-up, 1.7% (n=1) did not incorporate follow-up in study design, and the remainder were unknown. Only four studies with patients reported lost to follow-up provided an explanation for each patient. 10.3% (n=6) of RCTs conducted intention-to-treat analysis. The mean Jadad score was 2.14 ± 1.26, with no significant improvement over time (*p*=0.245).

**CONCLUSION:** We showed a significant increase in the number of RCTs published studying surgical treatment of CTS over time, however a mean Jadad score of 2.14 with no significant change over time suggests a need for improvement in quality. Although RCTs are level one evidence and there are many comparing surgical interventions for CTS, the majority employ flawed methodology. Proper study design is key to avoiding introduction of bias and ensuring the validity of conclusions drawn.
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